Paraneoplastic sensory ganglionopathy (Q85101): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
A neuronopatia sensitiva paraneoplásica (NSP) ocorre em pacientes com câncer e é desencadeada por mecanismos imunológicos. Tem um início subagudo, perda sensorial grave resultando em ataxia. O início pode ser assimétrico, geralmente começando nos braços e associado à dor neuropática. O sistema motor raramente está envolvido. Uma vez estabelecido, tem curso crônico e ininterrupto, incapacitando o paciente. NSP ocorre em associação com vários tipos de câncer, em particular SCLC._x000D_ _x000D_ Os autoanticorpos neurais associados são do tipo onconeural, predominantemente anti Hu. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Paraneoplastic sensory neuronopathy occurs in patients with cancer and is triggered by immune mechanisms. It has a subacute onset, severe sensory loss resulting in ataxia. The onset can be asymmetric, often beginning in the arms and associated with neuropathic pain. The motor system is rarely involved. Once established it has a chronic and unremitting course disabling the patient. SSN occurs in association with several cancer types, in particular SCLC. Associated neural autoantibodies are of the onconeural type, predominantly anti Hu. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/46072886 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_46072886 | |||||||||||||||
| Property / CURIE: CID11:ID_46072886 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_46072886 | |||||||||||||||
| Property / Canary Token: dki-india-ID_46072886 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 10:27, 15 August 2026
Paraneoplastic sensory neuronopathy occurs in patients with cancer and is triggered by immune mechanisms. It has a subacute onset, severe sensory loss resulting in ataxia. The onset can be asymmetric, often beginning in the arms and associated with neuropathic pain. The motor system is rarely involved. Once established it has a chronic and unremitting course disabling the patient. SSN occurs in association with several cancer types, in particular SCLC. Associated neural autoantibodies are of the onconeural type, predominantly anti Hu.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_46072886 |
||
| English | Paraneoplastic sensory ganglionopathy |
Paraneoplastic sensory neuronopathy occurs in patients with cancer and is triggered by immune mechanisms. It has a subacute onset, severe sensory loss resulting in ataxia. The onset can be asymmetric, often beginning in the arms and associated with neuropathic pain. The motor system is rarely involved. Once established it has a chronic and unremitting course disabling the patient. SSN occurs in association with several cancer types, in particular SCLC. Associated neural autoantibodies are of the onconeural type, predominantly anti Hu. |
Statements
CID11:ID_46072886
0 references
dki-india-ID_46072886
0 references
Concluído
0 references
13 August 2026
0 references
